Voyager Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview

Voyager Therapeutics

03/03/2023 15:47

* Voyager Therapeutics Inc  VYGR.OQ   VYGR.O  is expected
to show
a fall in quarterly revenue when it reports  results on March
7. 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 85.1% decrease in revenue to $4.187 million from $28.07
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Voyager
Therapeutics Inc
is for a loss of 55 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $10​, above​ its last closing price
of $7.22. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.31       -0.32      0.45      Beat    241.9
 Jun. 30 2022  -0.48       -0.32      -0.50     Missed  -57.5
 Mar. 31 2022  -0.25       -0.34      -0.56     Missed  -62.7​
 Dec. 31 2021  -0.71       -0.32      0.15      Beat    147.4
 ​​Sep.        -0.74       -0.73      -0.67     Beat    7.9
 30 2021                                                
 Jun. 30 2021  -0.72       -0.71      -0.80     Missed  -12.3​
 Mar. 31 2021  -0.66       -0.66      -0.58     Beat    11.6
 Dec. 31 2020  -0.57       -0.57      -0.43     Beat    23.9
 This summary was machine generated March 3 at 15:47 GMT.  All
figures in US dollars  unless otherwise stated